Susquehanna International Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-56,869
Closed -$12.5K 14294
2022
Q4
$12.5K Buy
+56,869
New +$17K ﹤0.01% 11895
2022
Q3
Sell
-68,497
Closed -$45K 14913
2022
Q2
$45K Sell
68,497
-18,626
-21% -$12.4K ﹤0.01% 12041
2022
Q1
$71K Sell
87,123
-88,052
-50% -$82.1K ﹤0.01% 12126
2021
Q4
$200K Buy
175,175
+50,803
+41% +$103K ﹤0.01% 11456
2021
Q3
$311K Buy
124,372
+41,595
+50% +$115K ﹤0.01% 10524
2021
Q2
$246K Sell
82,777
-30,184
-27% -$105K ﹤0.01% 11182
2021
Q1
$396K Sell
112,961
-103,465
-48% -$576K ﹤0.01% 10009
2020
Q4
$1.03M Buy
216,426
+130,170
+151% +$672K ﹤0.01% 6669
2020
Q3
$419K Buy
86,256
+53,092
+160% +$252K ﹤0.01% 8043
2020
Q2
$108K Buy
+33,164
New +$315K ﹤0.01% 9460

Other funds holding CEMI

Susquehanna International Group's CEMI Position: Q1 2023 in Review

Susquehanna International Group sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2023, closing a stake of 56,869 shares — an estimated $12.5K sold.

Susquehanna International Group first reported a position in CEMI in Q2 2020 and held it in 10 quarters. The position peaked at $1.03M in Q4 2020. 30 funds tracked by Wall St. Rank hold CEMI as of Q1 2023.

  • Susquehanna International Group reported no remaining Chembio diagnostics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 56,869 Chembio diagnostics, Inc. shares in Q1 2023, an estimated $12.5K.
  • Susquehanna International Group first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 10 quarters.
  • Susquehanna International Group's Chembio diagnostics, Inc. position peaked at $1.03M in Q4 2020.
  • 30 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.